Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,477 | -86,879 | -61,226 | -336 | -22,397 |
| Depreciation Amortization | 3,354 | 4,120 | 4,430 | 31,785 | 122 |
| Accounts receivable | N/A | N/A | N/A | -24,493 | N/A |
| Accounts payable and accrued liabilities | -1,852 | 2,191 | -473 | -249 | 1,200 |
| Other Working Capital | -11,952 | -5,835 | 45,196 | -48,630 | 861 |
| Other Operating Activity | 11,010 | 5,226 | 6,957 | -26,955 | -10,623 |
| Operating Cash Flow | $-59,917 | $-81,177 | $-5,116 | $-68,878 | $-30,837 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 73,540 | -27,900 | N/A | N/A |
| PPE Investments | -123 | -1,132 | -4,660 | -4 | -8 |
| Investing Cash Flow | $-123 | $72,408 | $-32,560 | $-4 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 35,000 | N/A | N/A |
| Debt Repayment | -1,429 | -1,301 | -865 | N/A | N/A |
| Common Stock Issued | 2,396 | 31,424 | 106 | 176,130 | 38,113 |
| Other Financing Activity | -623 | 32,057 | -922 | -1 | 0 |
| Financing Cash Flow | $344 | $62,180 | $33,319 | $176,129 | $38,113 |
| Beginning Cash Position | 77,605 | 24,194 | 28,551 | 55,409 | 48,141 |
| End Cash Position | 17,909 | 77,605 | 24,194 | 162,656 | 55,409 |
| Net Cash Flow | $-59,696 | $53,411 | $-4,357 | $107,247 | $7,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,917 | -81,177 | -5,116 | -68,878 | -30,837 |
| Capital Expenditure | -123 | -1,132 | -4,660 | -4 | -8 |
| Free Cash Flow | -60,040 | -82,309 | -9,776 | -68,882 | -30,845 |